A carregar...
CD4+/CD45RO+: A Potential Biomarker of the Clinical Response to Glatiramer Acetate
Background: Glatiramer acetate (GA) is an effective treatment for the earliest stages of multiple sclerosis (MS)—clinically isolated syndrome (CIS) or clinically definite MS (CDMS). Objective: This study aims to determine the differences in the lymphocyte population (at baseline and the course of fi...
Na minha lista:
| Publicado no: | Cells |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6562382/ https://ncbi.nlm.nih.gov/pubmed/31096621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells8050456 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|